Neuropace Inc (NQ: NPCE )
7.560
+0.560
(+8.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
All News about Neuropace Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
August 25, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace to Participate in Upcoming Investor Conferences
August 24, 2023
From NeuroPace, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
August 24, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
NeuroPace's Return On Capital Employed Overview
May 18, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: NeuroPace Q1 Earnings
May 04, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Looking Into NeuroPace's Return On Capital Employed
March 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_1872.jpeg?width=1200&height=800&fit=crop)
NeuroPace Earnings Preview
March 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 08, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/Los,Angeles,-,Feb,22:,Elon,Musk,At,The,Vanity.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
From NeuroPace, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/03/03/image48.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Friday's Intraday Session
March 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/03/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/03/image36.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
From NeuroPace, Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
February 22, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 10, 2023
From NeuroPace, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
January 16, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/10/image49.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
12 Health Care Stocks Moving In Monday's After-Market Session
January 02, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/d6e3d96b-0ad1-45ec-bf0e-f4e170959c70/small/neuropace-logo-png.png)
From NeuroPace, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.